Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Seneca Biopharma, Inc. (NASDAQ:SNCA.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SNCA.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

kzachmann (< 20)
Submitted December 13, 2012

The small molecules developed by CUR attack disease at the point of origin rather than just mitigation of symptoms. Eventually, once the science fine tunes the delivery system and the molecule targeting system a vast array of diseases will be helped… More

zzlangerhans (98.03)
Submitted January 12, 2017

Did you hear that? Me neither. That silence was the sound of Neuralstem not talking about NSI-566, their erstwhile lead program of stem cell therapy for ALS, spinal cord injury, and stroke. The last major development was in August 2015 when the… More

NASDAQ:SNCA.DL VS S&P 500 (SPY)

NASDAQ:SNCA.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about SNCA.DL.

No one has written a Pitch for SNCA.DL stock yet. Tell us why you think SNCA.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in SNCA.DL.

No players have picked SNCA.DL yet. Tell us why you think SNCA.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SNCA.DL.